In October 2021, Whipsnade Zoo in Bedfordshire lost a beloved 40‑year‑old southern white rhino. The animal’s passing seemed like the end of the line—until vets sprang into action. They carefully harvested a skin sample from the rhino’s ear and sent it to Nature’s SAFE, a wildlife biobanking charity based in Shropshire that specialises in preserving and reviving living cells from endangered species. Now, nearly four years later, that single sample has given rise to millions of new cells in culture. It’s a quietly remarkable moment that could lay the groundwork for future rhino births—and it’s likely the first time this kind of cell recovery has happened in the UK.
The science might sound like something out of a sci-fi film, but it’s very much real.
Nature’s SAFE works on the cutting edge of what’s called conservation biotechnology—bringing advanced tools like stem cell technology and IVF into the world of endangered wildlife. According to the BBC, this small breakthrough is the result of a careful collaboration between zoo vets, technicians, and conservationists determined not to let extinction win quietly.
When the rhino died, the team acted quickly to remove a skin sample and freeze it at −196 °C. For nearly four years, the sample sat preserved in liquid nitrogen. Then, in April 2025, it was thawed and reintroduced to the lab environment at Nature’s SAFE. Incredibly, the cells not only revived—they multiplied. Lab technician Lucy Morgan said the growth was even faster than expected, with healthy cultures forming in just over a week.
That kind of response is more than promising. These aren’t just random skin cells—they’re the foundation for future life. Using a process known as induced pluripotent stem cell (iPSC) technology, scientists can reprogram skin cells back into stem cells. From there, they could eventually be turned into egg or sperm cells. It’s a complex and experimental process, but one that’s already shown results in mice. If researchers can successfully apply it to rhinos, the possibilities open up.
The wider goal here isn’t just to grow cells—it’s to create a bank of living, functional cells from endangered animals before it’s too late. Nature’s SAFE calls this their “living biobank,” and it already includes tissue from around 300 different species, many of which are endangered or extinct in the wild. They’ve previously revived cells from coral, African wild dogs, and even amphibians that are on the brink.
In a statement shared with The Independent, the charity explained that skin cells are particularly useful because they’re easy to collect and can regenerate indefinitely. Once cryopreserved, they remain viable for decades. And that means the genetic diversity of a species isn’t permanently lost when an animal dies—it’s banked for the future.
Of course, the rhino species at the heart of this story—the southern white—aren’t the most critically endangered of the lot.
Their numbers are currently stable, sitting at around 16,000 across sub-Saharan Africa. But they’re not out of danger, either. Poaching, habitat loss, and low genetic diversity still threaten long-term survival. More urgently, their northern cousins are down to just two females, with no surviving males. Efforts like BioRescue are using IVF and southern white rhino surrogates to attempt to bring the northern subspecies back from the brink.
So, having a large reserve of viable cells—especially those recovered from individuals no longer alive—matters enormously. It opens the door to future breeding possibilities that don’t rely entirely on the shrinking gene pool of the living population. If this work continues and scales up, we may one day see embryos created from these cell lines and transferred into surrogates. That could mean new calves born with wider genetic variation and a better chance of surviving disease, climate stress, and long-term decline.
The ethical and practical sides of all this aren’t easy to ignore. The idea of creating life from a frozen skin sample might make some people uneasy. And it’s fair to say that lab-based conservation is no replacement for protecting wild habitats. But Nature’s SAFE doesn’t claim to offer a silver bullet. Instead, it’s providing a safety net—a way to preserve species when habitat restoration and anti-poaching efforts alone might not be enough. In many ways, it’s about buying time. Giving species one more tool to stay in the game.
There’s also the broader scientific value.
These techniques are still new, and the rhino breakthrough proves that they can be successfully applied here in the UK. It puts British conservation scientists on the global map and opens the door to further investment and collaboration. The European Association of Zoos and Aquaria (EAZA) has already supported biobanking efforts as part of its wider ex-situ conservation strategies, and results like these only make the case stronger.
There’s a long way to go. Turning skin cells into viable gametes in a large mammal like a rhino is still a frontier of science. IVF in rhinos has been achieved, but it remains technically tricky, expensive, and inconsistent. Success in cell culture doesn’t automatically translate into live births. But every step forward adds up. And a success like this one gives other endangered species a reason for hope.
In the meantime, the team at Nature’s SAFE will keep those millions of cells safe in storage, waiting for the science to catch up. And when it does, that ear sample from a rhino who died in a zoo could become the foundation for something remarkable: not just life recreated, but life continued. A way to make sure extinction isn’t always the final word.
It’s not just about one rhino. It’s about changing what’s possible in conservation. About realising that even when an animal dies, its future doesn’t necessarily have to. And in the quiet, cryogenic cold of a Shropshire lab, that future is being kept alive, cell by cell.